Page 72 - GPD-2-3
P. 72

Gene & Protein in Disease                                      Testosterone as a biomarker of colorectal cancer



            21.  Orsted DD, Nordestgaard BG, Bojesen SE, 2014, Plasma   Cancer Epidemiol Biomarkers Prev, 9(5): 517–521.
               testosterone in the general population, cancer prognosis and   32.  Hundt S, Haug U, Brenner H, 2007, Blood markers for early
               cancer risk: A prospective cohort study. Ann Oncol, 25(3):   detection of colorectal cancer: A systematic review. Cancer
               712–718.
                                                                  Epidemiol Biomarkers Prev, 16(10): 1935–1953.
               https://doi.org/10.1093/annonc/mdt590
                                                                  https://doi.org/10.1158/1055-9965.EPI-06-0994
            22.  Krasanakis  T,  Nikolouzakis  TK,  Sgantzos  M,  et al.,  2019,   33.  Locker GY, Hamilton S, Harris J, et al., 2006, ASCO 2006
               Role of anabolic agents in colorectal carcinogenesis: Myths   update of recommendations for the use of tumor markers in
               and realities (Review). Oncol Rep, 42(6): 2228–2244.
                                                                  gastrointestinal cancer. J Clin Oncol, 24(33): 5313–5327.
               https://doi.org/10.3892/or.2019.7351
                                                                  https://doi.org/10.1200/JCO.2006.08.2644
            23.  Ben-Batalla I, Vargas-Delgado ME, Von Amsberg G,   34.  Hyde Z, Flicker L, McCaul KA,  et  al., 2012, Associations
               et al., 2020, Influence of androgens on immunity to self and   between testosterone levels and incident prostate, lung,
               foreign: Effects on immunity and cancer.  Front Immunol,   and colorectal cancer. A  population-based study.  Cancer
               11: 1184.
                                                                  Epidemiol Biomarkers Prev, 21(8): 1319–1329.
               https://doi.org/10.3389/fimmu.2020.01184
                                                                  https://doi.org/10.1158/1055-9965.EPI-12-0129
            24.  Yang W, Giovannucci EL, Hankinson SE,  et  al., 2020,
               Endogenous sex hormones and colorectal cancer survival   35.  Chakraborty S, Pramanik J, Mahata B, 2021, Revisiting
               among men and women. Int J Cancer, 147(4): 920–930.  steroidogenesis and its role in immune regulation with the
                                                                  advanced tools and technologies. Genes Immun, 22(3): 125–140.
               https://doi.org/10.1002/ijc.32844
                                                                  https://doi.org/10.1038/s41435-021-00139-3
            25.  Khaw KT, Dowsett M, Folkerd E, et al., 2007, Endogenous   36.  Lee HK, Lee JK, Cho B, 2013, The role of androgen in
               testosterone and mortality due to all causes, cardiovascular   the adipose tissue of males.  World  J  Mens  Health, 31(2):
               disease, and cancer in men: European prospective
               investigation  into  cancer  in  Norfolk  (EPIC-Norfolk)   136–140.
               prospective population study. Circulation, 116: 2694–2701.     https://doi.org/10.5534/wjmh.2013.31.2.136
               https://doi.org/10.1161/circulationaha.107.719005  37.  Chen E, Xu X, Liu T, 2018, Hereditary nonpolyposis
                                                                  colorectal cancer and cancer syndromes: Recent basic and
            26.  Younis M, Arun M, Iqbal J, et al., 2018, Analysis of genetic   clinical discoveries. J Oncol, 2018: 3979135.
               alterations in colorectal cancer (CRC) patients in South
               Indian population. Int J Hum Genet, 18(3): 210–218.     https://doi.org/10.1155/2018/3979135
               https://doi.org/10.31901/24566330.2018/18.3.705  38.  Li H, Pham T, McWhinney BC, et al., 2016, Sex hormone
                                                                  binding globulin modifies testosterone action and
            27.  Harman SM, Metter EJ, Tobin JD, et al., 2001, Longitudinal
               effects of aging on serum total and free testosterone levels in   metabolism in prostate cancer cells.  Int J Endocrinol,
               healthy men. Baltimore longitudinal study of aging. J Clin   2016: 6437585.
               Endocrinol Metab, 86: 724–731.                     https://doi.org/10.1155/2016/6437585
               https://doi.org/10.1210/jcem.86.2.7219          39.  Roshni K, Younis M, Ilakkiyapavai D, et al., 2018, Anticancer
                                                                  activity of biosynthesized silver nanoparticles using Murraya
            28.  Chen CC, Yang SH, Lin JK, et al., 2005, Is it reasonable to
               add preoperative serum level of CEA and CA19-9 to staging   koenigii leaf extract against HT-29 colon cancer cell line.
               for colorectal cancer? J Surg Res, 124(2): 169–174.  J Cancer Sci Ther, 10(4): 72–75.
                                                                  https://doi.org/10.4172/1948-5956.1000521
               https://doi.org/10.1016/j.jss.2004.08.013
                                                               40.  Saddozai UA, Wang F, Akbar MU, et al., 2021, Identification of
            29.  Weissenberger C, Von Plehn G, Otto F,  et al., 2005,   clinical relevant molecular subtypes of pheochromocytoma.
               Adjuvant  radiochemotherapy  of  stage  II  and  III  rectal
               adenocarcinoma: Role of CEA and CA 19-9. Anticancer Res,   Front Endocrinol (Lausanne), 12: 605797.
               25(3A): 1787–1793.                                 https://doi.org/10.3389/fendo.2021.605797
            30.  Mohd Y, Balasubramanian B, Meyyazhagan A, et al., 2021,   41.  Saddozai UA, Wang F, Cheng Y, et al., 2020, Gene expression
               Extricating the association between the prognostic factors   profile identifies distinct molecular subtypes and potential
               of colorectal cancer. J Gastrointest Cancer, 52: 1022–1028.  therapeutic genes in Merkel cell carcinoma. Transl Oncol,
                                                                  13(11): 100816.
               https://doi.org/10.1007/s12029-020-00535-4
                                                                  https://doi.org/10.1016/j.tranon.2020.100816
            31.  Alberg AJ, Gordon GB, Hoffman SC,  et al., 2000, Serum
               dehydroepiandrosterone  and  dehydroepiandrosterone  42.  Akbar MU, Badar M, Zaheer M, 2022, Programmable drug
               sulfate and the subsequent risk of developing colon cancer.   release from a dual-stimuli responsive magnetic metal-


            Volume 2 Issue 3 (2023)                         9                        https://doi.org/10.36922/gpd.1082
   67   68   69   70   71   72   73   74   75   76   77